Saturation mutagenesis-reinforced functional assays for disease-related genes
Authors:
- 25 September 2024
- Vol. 187 (23) , 6707-6724.e22
Abstract
No abstract availableKeywords
Funding Information
- Muscular Dystrophy Association (629095)
- National Cancer Institute (P30 CA016359)
- National Institutes of Health (/ 5F32AR079892-02, P50NS053672)
- National Institute of Allergy and Infectious Diseases (MDA 963708, R01AI139238)
- Chan Zuckerberg Initiative (2022-309740)
- National Institute of Neurological Disorders and Stroke
- Howard Hughes Medical Institute
This publication has 115 references indexed in Scilit:
- The outcomes and experience of pregnancy in limb girdle muscular dystrophy type R9Muscle & Nerve, 2021
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- FAM3B/PANDER-Like Carbohydrate-Binding Domain in a Glycosyltransferase, POMGNT12020
- Variant Interpretation: Functional Assays to the RescueThe American Journal of Human Genetics, 2017
- Mutations in GMPPB Presenting with Pseudometabolic Myopathy2017
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Mutations in B3GALNT2 Cause Congenital Muscular Dystrophy and Hypoglycosylation of α-DystroglycanThe American Journal of Human Genetics, 2013
- DPM2‐CDG: A muscular dystrophy–dystroglycanopathy syndrome with severe epilepsyAnnals of Neurology, 2012
- Conditional knockout of protein O‐mannosyltransferase 2 reveals tissue‐specific roles of O‐mannosyl glycosylation in brain developmentJournal of Comparative Neurology, 2010
- New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian familiesneurogenetics, 2003